DEPOMED INC's ticker is and the CUSIP is 249908904. A total of 2 filers reported holding DEPOMED INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,435,000 | +16.3% | 215,100 | +14.9% | 0.01% | 0.0% |
| Q1 2018 | $1,234,000 | -42.9% | 187,200 | -30.3% | 0.01% | -20.0% |
| Q4 2017 | $2,163,000 | +91.9% | 268,700 | +38.0% | 0.02% | +50.0% |
| Q3 2017 | $1,127,000 | -39.0% | 194,700 | +13.1% | 0.01% | -47.4% |
| Q2 2017 | $1,849,000 | -47.7% | 172,200 | -38.9% | 0.02% | -53.7% |
| Q1 2017 | $3,535,000 | -48.4% | 281,700 | -26.0% | 0.04% | -38.8% |
| Q4 2016 | $6,857,000 | +275.3% | 380,500 | +420.5% | 0.07% | +235.0% |
| Q3 2016 | $1,827,000 | +65.9% | 73,100 | +30.3% | 0.02% | +53.8% |
| Q2 2016 | $1,101,000 | +14.3% | 56,100 | -18.8% | 0.01% | -7.1% |
| Q1 2016 | $963,000 | -23.8% | 69,100 | -0.9% | 0.01% | -6.7% |
| Q4 2015 | $1,264,000 | +35.2% | 69,700 | +40.5% | 0.02% | +15.4% |
| Q3 2015 | $935,000 | +296.2% | 49,600 | +350.9% | 0.01% | +333.3% |
| Q2 2015 | $236,000 | -87.0% | 11,000 | -86.4% | 0.00% | -89.3% |
| Q1 2015 | $1,811,000 | +429.5% | 80,800 | +281.1% | 0.03% | +460.0% |
| Q4 2014 | $342,000 | -48.7% | 21,200 | -51.7% | 0.01% | -50.0% |
| Q3 2014 | $667,000 | +28.0% | 43,900 | +17.1% | 0.01% | +25.0% |
| Q2 2014 | $521,000 | +1084.1% | 37,500 | +1150.0% | 0.01% | +700.0% |
| Q1 2014 | $44,000 | -75.0% | 3,000 | -81.9% | 0.00% | -66.7% |
| Q4 2013 | $176,000 | -34.8% | 16,600 | -54.0% | 0.00% | -40.0% |
| Q3 2013 | $270,000 | -43.2% | 36,100 | -57.4% | 0.01% | -58.3% |
| Q2 2013 | $475,000 | – | 84,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|